Erdem Ali Fuat, Yoruk Ozgur, Alici Haci Ahmet, Cesur Mehmet, Atalay Canan, Altas Enver, Kursad Husnu, Yuksek Mustafa Sahin
Department of Anesthesiology and Reanimation, Medical Faculty, Ataturk University, Erzurum, Turkey.
Paediatr Anaesth. 2008 Sep;18(9):878-83. doi: 10.1111/j.1460-9592.2008.02675.x.
Postoperative vomiting (POV) is a common complication after tonsillectomy. Dexamethasone is known to decrease postsurgical vomiting. In this study, we compared the effects of dexamethasone alone to dexamethasone plus propofol on postoperative vomiting in children undergoing tonsillectomy.
In a randomized double-blinded study, we evaluated 80 healthy children, aged 4-12 years, who underwent tonsillectomy with or without adenoidectomy. After anesthesia was induced by inhalation of sevoflurane, 0.15 mg x kg(-1) dexamethasone and 2 microg x kg(-1) fentanyl was administered i.v. to all patients. The patients in the dexamethasone plus propofol group received 1 mg x kg(-1) propofol before intubation and continuously after intubation at a rate of 20 microg x kg(-1) x min(-1) until the surgery was completed. Data for postoperative vomiting were grouped into the following time periods: 0-4 and 4-24 h. Data were analyzed using a Student's t-test and chi-squared analysis.
The percentage of patients exhibiting a complete response (defined as no retching or vomiting for 24 h) increased from 37.5% in the dexamethasone-alone group to 75% in the dexamethasone plus propofol group (P = 0.001). Twenty-two patients (55%) in the dexamethasone-alone and nine patients (22.5%) in the dexamethasone plus propofol groups experienced vomited during 0-4 h (P = 0.003). Eight patients in the dexamethasone-alone group and three patients in the dexamethasone plus propofol group received ondansetron as a rescue antiemetic during the postoperative period.
For children undergoing tonsillectomy, intraoperative subhypnotic propofol infusion combined with dexamethasone treatment provides a better prophylaxis against postoperative vomiting than does dexamethasone alone.
术后呕吐(POV)是扁桃体切除术后常见的并发症。已知地塞米松可减少术后呕吐。在本研究中,我们比较了单独使用地塞米松与地塞米松加丙泊酚对接受扁桃体切除术儿童术后呕吐的影响。
在一项随机双盲研究中,我们评估了80名4至12岁接受或未接受腺样体切除术的健康儿童。在吸入七氟醚诱导麻醉后,所有患者静脉注射0.15mg/kg地塞米松和2μg/kg芬太尼。地塞米松加丙泊酚组的患者在插管前接受1mg/kg丙泊酚,并在插管后以20μg/kg·min的速率持续输注直至手术结束。术后呕吐数据分为以下时间段:0至4小时和4至24小时。数据采用学生t检验和卡方分析进行分析。
完全缓解(定义为24小时内无干呕或呕吐)的患者百分比从单独使用地塞米松组的37.5%增加到地塞米松加丙泊酚组的75%(P = 0.001)。单独使用地塞米松组的22名患者(55%)和地塞米松加丙泊酚组的9名患者(22.5%)在0至4小时内出现呕吐(P = 0.003)。单独使用地塞米松组的8名患者和地塞米松加丙泊酚组的3名患者在术后期间接受了昂丹司琼作为抢救性止吐药。
对于接受扁桃体切除术的儿童,术中亚催眠剂量的丙泊酚输注联合地塞米松治疗比单独使用地塞米松能更好地预防术后呕吐。